Program and book of abstracts 1st conference

1 st Conference of European Academy for Molecular Hydrogen Research in Biomedicine “Hydrogen for Biomedicine“

He Qianjun

Dr. Qianjun He earned his PhD in 2010 from Shanghai Institute of Ceramics, Chinese Academy of Sciences, and was then assigned as an Assistant Professor there. He received a Marie Curie Fellowship and moved to University of Leeds in 2012. After two years, he joined the Laboratory of Molecular Imaging and Nanomedicine, NIBIB, NIH, as a postdoc. In 2015, he joined Shenzhen University as a Full Professor and the Chief of the Lab of Advanced Nanomedicines. In 2022, he moved to Shanghai Jiao Tong University (SJTU) and was appointed a Distinguished Professor and the Director of the R&D Center, Shenzhen Research Institute of SJTU. His research focuses on the engineering and development of intelligent nanomaterials and nanomedicines for precision theranostics and gas therapy of major diseases. He has pioneered a unique research field of “nanomaterials-mediated gas therapy”, and has published 100+ papers with an h-index of 55 on leading journals including Science Advances, Nature Communications, and Advanced Materials. He was recognized as a “Highly Cited Researcher” and as a “World’s Top 2% Scientists” with Career Scientific Impact. He is sitting the Associate Editors of Medical Gas Research and Chemical Synthesis. NANOMATERIALS – ENABLED PRECISION HYDROGEN THERAPY Center of Hydrogen Science, Shanghai Jiao Tong University, Shanghai 200240, China E-mail: qjhe@sjtu.edu.cn Hydrogen molecule has exhibited remarkable therapeutic effect against many inflammation-related diseases, and hydrogen therapy of cancer is receiving increasing attention since the inhalation of high pressure of hydrogen gas was discovered to be able to inhibit skin cancer in 1975. Hydrogen gas plays its cancer-selectivity and normal protection effects by targeting impacted cells. However, hydrogen gas molecule is highly aimless diffusible around the body. How to realize the targeted delivery and site-specific accumulation of hydrogen molecule is vitally important to augment its effects, but is still challenging. By virtue of nanotechnology, we propose to develop novel hydrogen-releasing nanomaterials for targeted delivery and controlled release of hydrogen to enhance hydrogen therapy efficacy. Recently, we have proposed a concept of nano-catalytic gas medicine, and developed a series of novel biocompatible hydrogen-producing nanocatalysts to realize sustainable hydrogen therapy. A new horizon of hydrogen therapy is arising from nanocatalytic medicine.

36